Obesity defined as a disease. Advances in artificial pancreas design to reduce complications in Type 1 diabetes. New developments with insulin delivery. The latest app for helping diabetics manage their condition. These are a just a few of the likely talking points at the 73rd Scientific Sessions for the American Diabetes Association (#2013ADA) underway in Chicago. If you want to follow the social media chatter around the event and beyond from several perspectives from an e-patient to a healthcare professional, to a drug developer and investor, here are nine people to follow on Twitter.
Dennis Urbaniak (@DUbaniak) is the vice president of diabetes at Sanofi-Aventis.
Christopher Snider (@iam_Spartacus) writes about his Type 1 Diabetes on his blog A Consequence of Hypoglycemia and is working at the #2013ADA conference.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Kerri Morrone Sparling (@sixuntilme) is a writer and social media consultant who authors the blog sixuntilme that charts Sparling’s experiences living with Type 1 diabetes.
Bea Dominguez (@crankypancreas) authors the blog Cranky Pancreas about Dominguez’s life with Type 2 diabetes.
John Brooks III (@JoslinCEO) is the CEO of Joslin Diabetes Center.
Ryan Luce (@Corengi) is the primary founder of Corengi, a website that helps type 2 diabetes patients find clinical trials that are right for them
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Jane Speight (@janespeight) is the foundation director for the Australian Centre for Behavioural Research in Diabetes in Melbourne.
Barbianne Davis (@Rnmama1) is a nurse at Heritage Valley Sewickley hospital.
John E. Milad (@jemilad) is a #medtech and #digitalhealth venture capitalist. He is an investment director at NBGI Ventures.
[Photo credit: Social media from BigStock Photos]
